Search Results

There are 9232 results for: content related to: Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma

  1. From Concept to the Clinics: Development of Novel Large Molecule Cancer Therapeutics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Balveen Kaur, Gregory B. Lesinski and Abhik Ray Chaudhury

    Published Online : 25 JUN 2010, DOI: 10.1002/9780470571224.pse402

  2. From Concept to the Clinics: Development of Cancer Therapeutics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Balveen Kaur, Gregory B. Lesinski and Abhik Ray Chaudhary

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse421

  3. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Article first published online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:

    Erratum

    Vol. 13, Issue 2, 335, Article first published online: 17 DEC 2009

  4. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A237–A460,

    Article first published online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_2.x

    Corrected by:

    Erratum

    Vol. 13, Issue 1, 158, Article first published online: 17 DEC 2009

  5. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  6. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A239–A250,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_1.x

  7. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  8. You have full text access to this OnlineOpen article
    Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality

    EMBO Molecular Medicine

    Volume 7, Issue 4, April 2015, Pages: 368–379, Alan McIntyre and Adrian L Harris

    Article first published online : 19 FEB 2015, DOI: 10.15252/emmm.201404271

  9. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

    British Journal of Surgery

    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Article first published online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  10. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  11. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  12. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  13. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  14. You have free access to this content
    POEMS syndrome: Update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 87, Issue 8, August 2012, Pages: 804–814, Angela Dispenzieri*

    Article first published online : 17 JUL 2012, DOI: 10.1002/ajh.23288

  15. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Article first published online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  16. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Article first published online : 7 MAY 2013, DOI: 10.1111/aos.12055

  17. Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery

    Acta Ophthalmologica

    Volume 93, Issue 7, November 2015, Pages: 667–678, Tine Van Bergen, Evelien Vandewalle, Lieve Moons and Ingeborg Stalmans

    Article first published online : 18 MAY 2015, DOI: 10.1111/aos.12766

  18. Antiangiogenic Therapy for Cancer: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1095–1111, Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L. DeRemer and Payaningal R. Somanath

    Article first published online : 3 DEC 2012, DOI: 10.1002/phar.1147

  19. Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

    Cancer

    Volume 121, Issue 9, May 1, 2015, Pages: 1456–1462, Jim Zhong, Arif N. Ali, Alfredo D. Voloschin, Yuan Liu, Walter J. Curran Jr, Ian R. Crocker and Hui-Kuo G. Shu

    Article first published online : 29 DEC 2014, DOI: 10.1002/cncr.29234

  20. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3